We were pleased to bring our newly expanded Scientific Advisory Board (SAB) together for our annual in-person meeting in Dallas, TX. Our advisors, R&D, Regulatory and Manufacturing teams shared our progress on ATX101, our scaling plans for our upcoming Phase 3 studies in the US and Japan, as well as updates on our pipeline of ultra-sustained products to treat post-surgical pain. SAB members include Art Tipton, Dr. Christine Allen, Ronald M. Burch, MD, PhD, Joachim Kohn and Louis Lazo Radulovic.
Allay Therapeutics’ Post
More Relevant Posts
-
Multiple times a week I am discussing: - The rationale for the use of IV robotics - The challenges with adopting this technology - How to prepare for and implementing IV robotics - The role this technology has played in improving safety Instead of just talking to me - I’m inviting you to listen to Arpit Mehta, Pharm.D., MPH, MHA, CPEL for free on Wednesday, April 10th! #ISMP #safety #robotics
Join ISMP and Arpit Mehta, PharmD, MPH, MHA, CPEL, Director of Pharmacy, AHN Allegheny General Hospital on April 10 for the CE-Accredited webinar "Leveraging IV Robotics to Optimize Sterile Compounding Practices to Improve Safety." Hear how AHN navigated implementation and adoption of this important technology and how it is driving clinical and operational outcomes success. Register Now! https://okt.to/lSmHN7
-
-
Following the conclusion of the ASLM Diagnostics Convention 2024, watch as our CEO, Mr. Nqobile Ndlovu, shares the driving factors behind hosting the conference and emphasizes the importance of shining a light on diagnostics and raising awareness of the role of laboratory medicine. #ASLMDiagnosticsConvention2024
-
Make sure to follow MEDFAR to get all the latest updates!
🌟 Exciting news! 🌟 We're thrilled to announce that we’ll be exhibiting at the 2024 Association for Diagnostics & Laboratory Medicine (ADLM) conference in Chicago! 🗓️ Join us from July 30 to August 1 for a showcase of our solutions; LABGEN LIS and MYLE RCM. 💬 Planning to attend? We'd love to see you! Feel free to stop by our booth anytime, or schedule a personalized meeting: https://bit.ly/medfar-adlm 📍 Visit us at booth #4058 ➡️ medfar.com #ADLM2024 #LIS #LIMS #RCM #MEDFAR #ADLM
-
-
Last week, Holger Senn presented at the PTC European Life Science Exchange event, discussing "AI in Variant and Configuration Lifecycle Management (CLM) of Medical Devices," with a focus on mastering complexity related to regulations and compliance. Holger presented the benefits medical device manufacturers can achieve using a CLM approach, including: - Standardizing processes - Capturing knowledge - One consistent data model Learn more about the benefits of a CLM approach by visiting https://lnkd.in/e8kzsktY #medicaldevice #manufacturing #complexitymanagement
On June 11, we held our 9th in-person European Life Science Exchange. We discussed the challenges, solutions, and benefits of digital solutions along the #digitalthread to revolutionize the life sciences industry. By embracing digital transformation, we can improve patient outcomes, navigate regulatory challenges, enhance quality, and contribute to a greener future. I thank our great speakers Dr. Dominik Siegel (Schölly Fiberoptics), Christian Vogelei (Fresenius Medical Care), Holger Senn (ConfigIt), Oliver Mutz (Inneo Solutions), Coen Jeukens (PTC), Dirk Schaefer (Roche Diagnostics), Helmut Draxler (Burckhardt Compression), and all attendees who joined us in Munich. Philipp Keller Jens Stephan Lea Loderer Isabella Federspiel Robert Grummt Yasmin Emamgholi, Ph.D. Alexandra Bitzer
-
Global Therapeutic Area Digital Marketing Lead 🔹️ Omnichannel 🔹️ Digital 🔹️Customer Experience 🔹️ Prescription 🔹️ Pharma 🔹️ Healthcare
Register now for the FREE webinar “Current Concepts in Medical Therapy for Glaucoma” on 22nd of June, sponsored by Viatris! Follow our esteemed experts Dr. Catherine Jui-Ling Liu, Prof. Makoto Aihara, Dr. Dewang Angmo and Assoc. Prof. Yanin Suwan as they talk about latest breakthroughs and management strategies in glaucoma therapy. Sign up here: https://lnkd.in/gbyNiZfy Subscribe to our Youtube channel and never miss our latest webinars: https://lnkd.in/gbUZyK3j
-
-
We are back with 'Lessons from the SV95C qualification Series'. In 2023, Sysnav and its partners qualified SV95C, the first digital primary endpoint to the European Medicines Agency (EMA). In the next few months, we'll share our biggest takeaways from the qualification. 🤝 Lesson 2: It takes a village Creating meaningful endpoints requires interaction between physicians, engineers, patient associations, and regulators. Digital endpoints should be: 👉 Meaningful for patients 👉 Used by clinicians 👉 Trusted by regulators The SV95C EMA qualification is the result of collaboration with University of Oxford, Roche, Parent Project Muscular Dystrophy, Muscular Dystrophy UK, World Duchenne Organization, and many others.
-
-
Get inspired by our product users! During our recent Nordic User Meeting, several laboratory professionals shared interesting clinical cases from Denmark, Norway, and Sweden, showcasing the impact of digital cell morphology on daily laboratory operations. Dive deeper into these insights by watching our webinars: https://lnkd.in/dJeHJt56
-
-
Are you joining us at PSI 2024 next week? Make sure to stop by James Matcham's presentation "Advanced Trial Simulation in the Design of a Pivotal Cardiovascular Study: A Case Study" to discover how Cytel anticipates future developments both in the industry and across your therapeutic journey to ensure you always stay ahead of the curve! Can't make it? Stop by booth 18 any day and speak to our experts! Book a meeting here: https://hubs.ly/Q02B17jn0 #PSI #Biostatistics #HTA
-
Enjoyed this discussion with Patricia Roselle about how Velocity Clinical Research, Inc. and Sanofi are putting patients first in clinical research. Much more to come from this collaboration. Thanks Jimmy Bechtel, MBA!
In this episode, Nick Spittal from Velocity Clinical Research, Inc. and Patricia Roselle with Sanofi celebrate Velocity's win of the 2023 Excellence in Patient Centricity Award. Hear insights from Velocity and Sanofi on the importance of patient-centricity and the initiatives that led to this award. Plus, we'll explore the future goals of both organizations in advancing clinical research with a patient-focused approach. ⇢ https://lnkd.in/dEu6-pM
-
-
Great to see Steph Eaneff showcasing the process we use to learn and develop our products in this poster presented at @DTx West. By iterating on clinical studies, testing new concepts, and generating new hypotheses to validate in future studies, we’re creating the dynamic cycle that keeps Woebot well ahead. #dtx #digitaltherapeutics #digitalhealth #digitalhealthinnovation
-
Distinguished Professor Emeritus at Rutgers University, President of IUSBSE, and President of BMK Scientific Consulting, Inc.
1wThis is a very good group to work with. I am delighted to be a part of it.